SCHEMBL23012167

SCHEMBL23012167

O=C(O)c1cc(-c2cc3cc(NC(=O)[C@@H]4C[C@@H]4F)ccc3o2)ccn1

nearest known ligand 0.39

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ TYK2 P29597 6/20 0.39
▸ BUB1 O43683 6/20 0.37
▸ ABL1 P00519 8/20 0.36
▸ KIT P10721 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23033609 0.84 SYK (0.42) —
SCHEMBL30850818 0.83 ALDH1A1 (0.49) —
SCHEMBL23012294 0.83 ALDH1A1 (0.49) —
SCHEMBL23033316 0.81 ALDH1A1 (0.41) —
SCHEMBL23012327 0.81 CASP3 (0.47) TYK2ABL1KIT
SCHEMBL23033375 0.79 NPC1 (0.47) BUB1ABL1
SCHEMBL28714600 0.78 ALDH1A1 (0.44) —
SCHEMBL28714690 0.74 BUB1 (0.32) BUB1
SCHEMBL23012967 0.73 MAPT (0.51) —
SCHEMBL23012765 0.73 MAPT (0.51) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114269725-B Anti-influenza virus compound, preparation method and application thereof 西藏海思科制药有限公司 2024-09-17 — — CN disclosed
US-20230079045-A1 ANTI-INFLUENZA VIRUS COMPOUND, PREPARATION METHOD AND USE THEREOF SICHUAN HAISCO PHARMACEUTICAL CO., LTD. (CN) 2023-03-16 — — US disclosed
CN-114269725-A Anti-influenza virus compound and preparation method and application thereof 四川海思科制药有限公司 2022-04-01 — — CN disclosed
WO-2021032209-A1 ANTI-INFLUENZA VIRUS COMPOUND, PREPARATION METHOD AND USE THEREOF 四川海思科制药有限公司 2021-02-25 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230079045-A1 ANTI-INFLUENZA VIRUS COMPOUND, PREPARATION METHOD AND USE THEREOF IDE, ACE, SI TYK2 4202/4885BUB1 3295/4885ABL1 711/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback